Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
8.07
-0.19 (-2.24%)
At close: Sep 15, 2025, 4:00 PM EDT
8.19
+0.13 (1.55%)
Pre-market: Sep 16, 2025, 6:22 AM EDT
Trevi Therapeutics Employees
Trevi Therapeutics had 26 employees as of December 31, 2024. The number of employees increased by 1 or 4.00% compared to the previous year.
Employees
26
Change (1Y)
1
Growth (1Y)
4.00%
Revenue / Employee
n/a
Profits / Employee
-$1,819,154
Market Cap
982.13M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 26 | 1 | 4.00% |
| Dec 31, 2023 | 25 | 0 | - |
| Dec 31, 2022 | 25 | 1 | 4.17% |
| Dec 31, 2021 | 24 | 2 | 9.09% |
| Dec 31, 2020 | 22 | 5 | 29.41% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TRVI News
- 6 days ago - Trevi Therapeutics, Inc. (TRVI) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 18 days ago - Trevi Therapeutics to Participate in Upcoming September Conferences - PRNewsWire
- 5 weeks ago - Trevi Therapeutics, Inc. (TRVI) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Trevi Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates - PRNewsWire
- 6 weeks ago - Trevi Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Corporate Update on August 7, 2025 - PRNewsWire
- 6 weeks ago - Trevi Therapeutics to Participate in Upcoming August Conferences - PRNewsWire
- 2 months ago - Trevi Therapeutics to Attend Leerink Partners Therapeutics Forum: I&I and Metabolism - PRNewsWire
- 3 months ago - Trevi Therapeutics Announces Closing of $115 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares - PRNewsWire